The Gross Margin of JW (Cayman) Therapeutics Co Ltd (2126.HK) is 48.87%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 48.87% |
| 2023-12-31 | 50.74% |
| 2022-12-31 | 40.33% |
| 2021-12-31 | 29.37% |
| 2020-12-31 | 29.37% |